Allan S. Wagman

3.1k citations

28 papers · 2.2k indexed · 1 hit paper · h-index 17

Co-authors: Céline Charvet Douglas R. Green Emmanuel Dejardin Ulrich Maurer Stephen F. Martin Kirk W. Johnson Jérôme Ruzzin Jørgen Jensen
Topics: Wnt/β-catenin signaling in development and cancer (4 papers)Cancer therapeutics and mechanisms (3 papers)Organophosphorus compounds synthesis (3 papers)
Cited by: Molecular Biology Organic Chemistry Cancer Research
Journals: Journal of the American Chemical Society Molecular Cell Cancer Research
Partner nations: United States Japan Norway

In The Last Decade

Allan S. Wagman

26 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glycogen Synthase Kinase-3 Regulates Mitochondrial Outer Membrane Permeabilization and Apoptosis by Destabilization of MCL-1

2006 705 citations Ulrich Maurer, Céline Charvet et al. Molecular Cell profile →

Peers

Countries citing papers authored by Allan S. Wagman

Since Specialization

Citations

This map shows the geographic impact of Allan S. Wagman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan S. Wagman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan S. Wagman more than expected).

Fields of papers citing papers by Allan S. Wagman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan S. Wagman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan S. Wagman. The network helps show where Allan S. Wagman may publish in the future.

Co-authorship network of co-authors of Allan S. Wagman

This figure shows the co-authorship network connecting the top 25 collaborators of Allan S. Wagman. A scholar is included among the top collaborators of Allan S. Wagman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan S. Wagman. Allan S. Wagman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery and optimization of novel pyridines as highly potent and selective glycogen synthase kinase 3 inhibitors 2019 ·Bioorganic & Medicinal Chemistry Letters ·Savithri Ramurthy,Keith Pfister,(unknown),Sean P. Brown,(unknown),Manoj C. Desai,Eric Fang,Barry H. Levine,Simon C. Ng,John M. Nuss,David B. Ring,Cynthia M. Shafer,Wei Shu,Sharadha Subramanian,Allan S. Wagman,Haixia Wang,Dirksen E. Bussiere	11
2	Fatty acid synthase – Modern tumor cell biology insights into a classical oncology target 2017 ·Pharmacology & Therapeutics ·Douglas Buckley,Gregory Duke,Timothy S. Heuer,Marie O’Farrell,Allan S. Wagman,William McCulloch,George Kemble	151
3	Synthesis and Microbiological Evaluation of Novel Tetracyclic Fluoroquinolones 2017 ·ChemMedChem ·Allan S. Wagman,Ryan T. Cirz,Glenn McEnroe,James B. Aggen,Martin S. Linsell,(unknown),Sara López,Marcela Gómez,(unknown),(unknown),Thomas R. Belliotti,Christina R. Harris,(unknown),(unknown),R.D. Gaston,Heinz E. Moser	20
4	Establishing the foundation for a novel, first-in-class, fatty acid synthase inhibitor, TVB-2640, for the treatment of NASH 2017 ·Journal of Hepatology ·Gerald J. Duke,Allan S. Wagman,Douglas Buckley,William McCulloch,George Kemble	4
5	Exploring the active site of the Streptococcus pneumoniae topoisomerase IV–DNA cleavage complex with novel 7,8-bridged fluoroquinolones 2016 ·Open Biology ·Ivan Laponogov,(unknown),Dennis A. Veselkov,Ryan T. Cirz,Allan S. Wagman,Heinz E. Moser,L. Mark Fisher,Mark R. Sanderson	23
6	Glycogen Synthase Kinase-3 Regulates Mitochondrial Outer Membrane Permeabilization and Apoptosis by Destabilization of MCL-1breakdown → 2006 ·Molecular Cell ·Ulrich Maurer,Céline Charvet,Allan S. Wagman,Emmanuel Dejardin,Douglas R. Green	705
7	4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Zhi‐Jie Ni,Paul A. Barsanti,(unknown),(unknown),Daniel J. Poon,Simon S.M. Ng,Sabina Pecchi,Keith Pfister,Paul A. Renhowe,Savithri Ramurthy,Allan S. Wagman,Dirksen E. Bussiere,Vincent Le,Yasheen Zhou,Johanna M. Jansen,Sylvia Ma,Thomas G. Gesner	58
8	Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor 2005 ·Diabetologia ·Jérôme Ruzzin,Allan S. Wagman,Jørgen Jensen	189
9	Discovery and Development of GSK3 Inhibitors for the Treatment of Type 2 Diabetes 2004 ·Current Pharmaceutical Design ·Allan S. Wagman,Kirk W. Johnson,Dirksen E. Bussiere	127
10	Progress and development of small molecule HCV antivirals. 2004 ·PubMed ·Zhi‐Jie Ni,Allan S. Wagman	34
11	Selective Glycogen Synthase Kinase 3 Inhibitors Potentiate Insulin Activation of Glucose Transport and Utilization In Vitro and In Vivo 2003 ·Diabetes ·David B. Ring,Kirk W. Johnson,Erik J. Henriksen,John M. Nuss,Dane A. Goff,Tyson R. Kinnick,(unknown),(unknown),(unknown),(unknown),Allan S. Wagman,(unknown),Stephen D. Harrison	406
12	Simple and Efficient Synthesis of 3,4-Dihydro-2-pyridones via Novel Solid-Supported Aza-Annulation 2000 ·The Journal of Organic Chemistry ·Allan S. Wagman,Liang Wang,John M. Nuss	17
13	The Total Synthesis of (±)-Ginkgolide B 2000 ·Journal of the American Chemical Society ·Michael T. Crimmins,(unknown),Philippe G. Nantermet,(unknown),James B. Thomas,Scott H. Watterson,Allan S. Wagman	82
14	Synthesis and Kinetic Evaluation of Inhibitors of the Phosphatidylinositol-Specific Phospholipase C from Bacillus cereus 1996 ·The Journal of Organic Chemistry ·Stephen F. Martin,Allan S. Wagman	13
15	Ring-closing olefin meta thesis for the synthesis of fused nitrogen heterocycles 1996 ·Tetrahedron ·Stephen F. Martin,(unknown),(unknown),Yusheng Liao,Michael Pätzel,(unknown),Allan S. Wagman	87
16	A long-wavelength biolabeling reagent based on the oxonol fluorophore 1995 ·Journal of Fluorescence ·Philip L. Southwick,Klaus M. Hahn,Jean Chao,(unknown),Allan S. Wagman,M. Wagner,Alan S. Waggoner	2
17	A novel approach to FR-900482 via ring forming metathesis 1995 ·Tetrahedron Letters ·Stephen F. Martin,Allan S. Wagman	49
18	General Route to Phosphonodithioic Acid Derivatives 1994 ·The Journal of Organic Chemistry ·Stephen F. Martin,Allan S. Wagman,Gabriela Zipp,(unknown)	5
19	A general and efficient route to phosphorodithioate analogs of naturally occurring lipids 1993 ·The Journal of Organic Chemistry ·Stephen F. Martin,Allan S. Wagman	10
20	SYNTHESIS OF 1,1′-BIS(2-SULFOETHYL)PURPURATE(BISEP) TRISODIUM AND TRIPOTASSIUM SALTS. MEMBRANE IMPERMEANT CALCIUM INDICATORS FOR MUSCLE CONTRACTION STUDIES 1991 ·Organic Preparations and Procedures International ·Philip L. Southwick,Allan S. Wagman,Alan S. Waggoner	0

About Allan S. Wagman

Allan S. Wagman is a scholar working on Molecular Medicine, Organic Chemistry and Toxicology, having authored 28 papers that have together received 2.2k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (4 papers), Cancer therapeutics and mechanisms (3 papers) and Organophosphorus compounds synthesis (3 papers). The work is most often cited by research in Molecular Biology (1.4k citations), Organic Chemistry (447 citations) and Cancer Research (217 citations). Allan S. Wagman has collaborated with scholars based in United States, Japan and Norway. Frequent co-authors include Céline Charvet, Douglas R. Green, Emmanuel Dejardin, Ulrich Maurer, Stephen F. Martin, Kirk W. Johnson, Jérôme Ruzzin, Jørgen Jensen, Dirksen E. Bussiere and John M. Nuss. Their work appears in journals such as Journal of the American Chemical Society, Molecular Cell and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact